10-Q Filing

REGENXBIO INC. CIK: 1590877 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001564590-17-016550`
Period End Date	20170630
Filing Date	20170808
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	rgnx-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 78 Cash Flow Statement 58 Comprehensive Income 1

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$57.65M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$30.08M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$64.71M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$104.43M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$50.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$1.03M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.77M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.43M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.48M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.85M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.01M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.25M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$93.37M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.48M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$165.82M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.85M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$69.41M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$46.42M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.52M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.32M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$393.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$400.00K	USD	Point-in-time
Total assets	`Assets`	$172.73M	USD	Point-in-time
Total assets	`Assets`	$224.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.54M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.95M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$7.51M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$8.13M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.67M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.33M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.22M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.68M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at June 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at June 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at June 30, 2017 and December 31, 2016; 30,853 and 26,477 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at June 30, 2017 and December 31, 2016; 30,853 and 26,477 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$363.39M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$276.35M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-646.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-33.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-151.05M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-114.59M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$161.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$211.70M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$172.73M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$224.38M	USD	Point-in-time

Income Statement 78 line items

Line Item	Tag	Value	Unit	Period
License revenue	`LicensesRevenue`	$6.55M	USD	1 Quarter
License revenue	`LicensesRevenue`	$2.25M	USD	1 Quarter
License revenue	`LicensesRevenue`	$7.01M	USD	2 Qtrs
License revenue	`LicensesRevenue`	$2.57M	USD	2 Qtrs
Reagent sales	`OtherSalesRevenueNet`	$166.00K	USD	2 Qtrs
Reagent sales	`OtherSalesRevenueNet`	$107.00K	USD	1 Quarter
Grant revenue	`GrantsRevenueExpenses`	$7.00K	USD	2 Qtrs
Grant revenue	`GrantsRevenueExpenses`	$29.00K	USD	2 Qtrs
Grant revenue	`GrantsRevenueExpenses`	$23.00K	USD	1 Quarter
Grant revenue	`GrantsRevenueExpenses`	$7.00K	USD	1 Quarter
Total revenues	`Revenues`	$2.77M	USD	2 Qtrs
Total revenues	`Revenues`	$6.56M	USD	1 Quarter
Total revenues	`Revenues`	$2.38M	USD	1 Quarter
Total revenues	`Revenues`	$7.02M	USD	2 Qtrs
Licensing costs	`LicenseCosts`	$1.40M	USD	2 Qtrs
Licensing costs	`LicenseCosts`	$1.31M	USD	1 Quarter
Licensing costs	`LicenseCosts`	$449.00K	USD	1 Quarter
Licensing costs	`LicenseCosts`	$515.00K	USD	2 Qtrs
Costs of reagent sales	`CostOfGoodsSold`	$6.00K	USD	1 Quarter
Costs of reagent sales	`CostOfGoodsSold`	$49.00K	USD	1 Quarter
Costs of reagent sales	`CostOfGoodsSold`	$79.00K	USD	2 Qtrs
Costs of reagent sales	`CostOfGoodsSold`	$6.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$13.92M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$30.54M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$10.68M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$16.86M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.36M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$12.98M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.17M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$11.65M	USD	2 Qtrs
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$-74.00K	USD	2 Qtrs
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$134.00K	USD	2 Qtrs
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$-29.00K	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$20.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$17.33M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$44.99M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$21.62M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$28.97M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-37.98M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-14.95M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-26.20M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-15.06M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$1.51M	USD	2 Qtrs
Investment income	`InvestmentIncomeNet`	$998.00K	USD	2 Qtrs
Investment income	`InvestmentIncomeNet`	$515.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$583.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$583.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$998.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$515.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.51M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-25.20M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-36.47M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-14.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.44M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities,net of reclassifications of $480 for the six months ended June 30, 2017	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-74.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities,net of reclassifications of $480 for the six months ended June 30, 2017	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.24M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities,net of reclassifications of $480 for the six months ended June 30, 2017	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$246.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities,net of reclassifications of $480 for the six months ended June 30, 2017	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-613.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$246.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.24M	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-613.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-74.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-37.08M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-14.55M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-14.19M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-23.96M	USD	2 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-14.47M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-14.44M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.47M	USD	2 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-25.20M	USD	2 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-1.27	USD	2 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.96	USD	2 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.47	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.55	USD	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.66M	shares	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	28.68M	shares	2 Qtrs
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.36M	shares	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.34M	shares	2 Qtrs

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-25.20M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-36.47M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-14.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.44M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$5.07M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$3.20M	USD	2 Qtrs
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-987.00K	USD	2 Qtrs
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-945.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.26M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$104.00K	USD	2 Qtrs
Realized gains on sales of marketable securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$480.00K	USD	2 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-40.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.35M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-982.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$460.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$657.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$586.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$242.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$98.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$86.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$2.72M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$930.00K	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.98M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-31.00K	USD	2 Qtrs
Advance payments	`IncreaseDecreaseInCustomerAdvances`	$-127.00K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$-89.00K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$601.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-16.32M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-27.03M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$32.26M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$46.59M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$26.13M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$28.01M	USD	2 Qtrs
Sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$780.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.61M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.49M	USD	2 Qtrs
Restricted cash	`IncreaseDecreaseInRestrictedCash`	$225.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-7.85M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-22.41M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$329.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$130.00K	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$147.00K	USD	2 Qtrs
Proceeds from public offering of common stock, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStock`	$81.99M	USD	2 Qtrs
Issuance costs for public offering of common stock	`PaymentsOfStockIssuanceCosts`	$219.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$82.25M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$130.00K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-24.03M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$32.81M	USD	2 Qtrs
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$57.65M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$30.08M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$57.65M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$30.08M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$939.00K	USD	2 Qtrs
Issuance costs for public offering of common stock in accounts payable and accrued expenses	`DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction`	$193.00K	USD	2 Qtrs

Comprehensive Income 1 line items

Line Item	Tag	Value	Unit	Period
Unrealized gain (loss) on available-for-sale securities, net of reclassifications	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$480.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.